4
Feb
2025
DeepSeek Shocked Silicon Valley, but It’s Not Earth Shaking for Biotech
DeepSeek, the artificial intelligence (AI) research group owned by Chinese hedge fund High-Flyer, dominated last week’s news cycle—at least for 24-48 hours. The group launched R1, the latest in a series of cutting-edge large language models (LLMs). Investors panicked, erasing over $1 trillion of U.S. equity market cap in a single day. Nvidia (NVDA), the maker of high-powered AI chips,... Read More
5
Dec
2024
Computational Techniques Are Driving a Tidal Shift in Therapeutic Protein Design
I recently attended the Molecular Machine Learning (MoML) Conference sponsored by the MIT Jameel Clinic, an institute focused on cutting-edge machine learning (ML) techniques in the life sciences. Computational approaches to drug discovery and development were the centerpiece of the symposium. Investor sentiment for ML-centric discovery biotechs has been turbulent recently, but researchers at MoML were widely and consistently enthusiastic.... Read More